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Abstract
Equine Multiple Congenital Ocular Anomalies (MCOA) syndrome is a heritable eye disorder mainly affecting silver
colored horses. Clinically, the disease manifests in two distinct classes depending on the horse genotype. Horses
homozygous for the mutant allele present with a wide range of ocular defects, such as iris stromal hypoplasia,
abnormal pectinate ligaments, megaloglobus, iridociliary cysts and cataracts. The phenotype of heterozygous horses
is less severe and predominantly includes iridociliary cysts, which occasionally extend into the temporal retina. In
order to determine the genetic cause of MCOA syndrome we sequenced the entire previously characterized 208
kilobase region on chromosome 6 in ten individuals; five MCOA affected horses from three different breeds, one
horse with the intermediate Cyst phenotype and four unaffected controls from two different breeds. This was
performed using Illumina TruSeq technology with paired-end reads. Through the systematic exclusion of all
polymorphisms barring two SNPs in PMEL, a missense mutation previously reported to be associated with the silver
coat colour and a non-conserved intronic SNP, we establish that this gene is responsible for MCOA syndrome. Our
finding, together with recent advances that show aberrant protein function due to the coding mutation, suggests that
the missense mutation is causative and has pleiotrophic effect, causing both the horse silver coat color and MCOA
syndrome.
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Introduction
Equine Multiple Congenital Ocular Anomalies (MCOA)
syndrome consists of different combinations of clinical
symptoms that affect the anterior and posterior segment of the
eye. While the syndrome was first described in the Rocky
Mountain Horse, where it is highly prevalent, it is not limited to
this breed. Additional horse breeds that have been diagnosed
with MCOA syndrome include the Icelandic Horse, Shetland
Pony, Exmoor Pony, American Miniature Horse, Belgian Draft
and Morgan Horse, as well as the Kentucky Mountain Saddle
Horse and Mountain Pleasure Horse, both of which are closely
related to the Rocky Mountain Horse [1,2,3,4,5,6,7]. MCOA
syndrome is inherited as an incompletely dominant trait.
Horses with the MCOA phenotype are homozygous for the
disease allele and have a wide range of eye anomalies (Figure
1a and b). These include, but are not restricted to, uveal cysts,
cornea globosa, iris stromal hypoplasia, abnormal pectinate
ligaments, cataracts and iris hypoplasia [1,8,9]. Horses that are
heterozygous for the disease causing allele have the less
severe Cyst phenotype which mainly consists of cysts that
originate from the temporal ciliary body, iris, and/or extend into
the temporal, peripheral retina [10,11]. The majority of MCOA
syndrome horses also have the valued Silver coat color (Figure
1c). This coat phenotype is characterized by the dilution of
black pigment in the hair and is most visible in the mane and
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tail. The Silver coat color is associated with a missense
mutation in exon 11 of premelanosome protein (PMEL) [12,13].
It is not possible to see if a horse carries the Silver mutation on
a chestnut background. However, these horses also display the
disease phenotype. Selective breeding for the Silver coat color
has simultaneously increased the frequency of MCOA
syndrome in many breeds as both traits are closely linked on
horse chromosome 6 [14].
Mutations in PMEL have previously been shown to regulate
hypopigmented phenotypes in mice, chickens, zebrafish, dogs
and cattle [15,16,17,18,19]. Only the zebrafish and dog have
been reported to have concurrent ocular anomalies, although
the clinical presentation in these species is quite different from
that observed in the horse [18,20,21]. The zebrafish mutant,
fading vision, is characterized by hypopigmented retinal
pigment epithelium (RPE) and body melanocytes. Due to
defects in RPE, the outer segments of photoreceptors are
either strongly reduced in length or are completely absent.
Interestingly, the retina of adults shows a partial recovery to
normal morphology [18]. No abnormalities in the other
Figure 1.  Clinical signs of MCOA syndrome and a Silver
colored Rocky Mountain Horse.  A) Single or multiloculated
cysts originating from the ciliary body, iris and occasionally
extending into the retina in the temporal quadrant of the eye is
the hallmark of the Cyst phenotype and frequently observed in
horses with the MCOA phenotype. However, in the MCOA
phenotype, other intraocular anomalies, such as cataracts and
mitotic pupils, may block the view of the temporal part of the
posterior chamber and peripheral retina. B) The right eye of a
Rocky Mountain Horse with ectropion uvea, dyscoria, cataract,
and lens subluxation. The granula iridica is hypoplastic, the
pupil is misshapen, and circumferential ectropion uvea is
present. Nuclear cataract of the nuclearcortical junction is
present. Vitreous is present in the anterior chamber between
the iris and lens secondary to posterior ventral lens
subluxation. C) A shiny white mane and tail, in conjunction with
a slightly diluted body color with dapples, is typical of a
genetically black Silver colored horse. This horse has also
been diagnosed with MCOA. Reprinted from Andersson et al.,
BMC Genetics 2008, 9:88.
doi: 10.1371/journal.pone.0075639.g001
structures of the eye were reported. PMEL mutant dogs are
called “merles” and typically have blue eyes. The coats of
heterozygous dogs are characterized by patches of diluted
pigment intermingled with normal hairs, while the coat of
homozygous dogs are predominantly white or very pale [19].
One study reported that 54.6% of double merle dogs had mild
to severe deafness [22]. To a lesser extent homozygous merle
dogs also have an elevated frequency of ocular anomalies
including microphthalmia, microcoria, colobomas and
increased ocular pressure [20,21]. Merle in the homozygous
condition has also been reported to be sublethal due to
negative pleiotropic effects on the skeleton, cardiac and
reproductive systems [22]. However, not all double merles
seem to be affected by theses pleiotropic effects. The reason
for this may include modifying genotypes at other loci, strong
linkage disequilibrium (LD) between the causative mutation and
PMEL (which is positioned in a very gene dense region), or the
length variation noted in the SINE element associated with the
merle phenotype [22]. Unexpectedly, the SINE element has
also been found in a few non-merle dogs [19].
The kinds of mutations identified in PMEL are both numerous
and varied, and their phenotypic effects are quite diverse. It is
so far not known if any of these mutations completely disrupt
protein function. In order to study complete loss of function of
PMEL, a mouse line with inactivated Pmel has recently been
created [23]. This study showed that Pmel inactivated mice
have a minor visible dilution of the coat color and that their
melanosomes are spherical, instead of the rod shape present
in wild-type animals. Interestingly, no ocular anomalies could
be detected in these animals. The very subtle effects of
completely disrupting PMEL suggests that PMEL mutant
species with more pronounced phenotypic alterations, like the
horse, carry dominant negative mutations. In yet another recent
study of the biochemical properties of PMEL function, it was
shown that mutations in or near the transmembrane domain of
PMEL, like the Silver mutation in horse and Dominant white
chicken, change the capacity of this region to self-associate
[24]. These small in-frame mutations alter fibril formation into
more compact structures and this in turn leads to severe
pigment loss. Although the effect of the mutation causing the
Dominant white phenotype in chicken was proved to be similar
to that in the horse, ocular examination of these birds did not
identify any ocular anomalies [25].
MCOA syndrome was previously mapped to a 208 kilo-base
region on horse chromosome 6 (Andersson et al. 2011b). The
region is gene dense and contains several genes that have
been proposed to be involved in ocular development or
disease. This study aimed at identifying the causative mutation
of MCOA syndrome and in doing so, evaluate if PMEL is
involved in this eye disease. Further, as the popularity of the
Silver coat color is increasing across several horse breeds the
results may also have important implications for informed
breeding decisions. By next generation DNA sequencing we
have managed to exclude all genes, except PMEL, as being
causative for both the MCOA syndrome and the Silver coat
color in horses.
Mutant PMEL Causes MCOA Syndrome
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Results
Generation of sequence data
In order to find the causative mutation for MCOA syndrome
we deep sequenced five homozygous MCOA horses from
three different breeds, one horse with the heterozygous Cyst
phenotype and four unaffected controls (Table 1). In total we
generated 36 Gb of sequence data (Study accession: http://
www.ebi.ac.uk/ena/data/view/PRJEB4316, European
Nucleotide Archive). For unknown reasons horse number 10,
an unaffected Rocky Mountain Horse, generated almost five
times more data (Table 1). On average, 93.4% of the reads
from each horse could be mapped to the MCOA identity-by-
decent (IBD) interval with an average coverage of 16,468 X.
We did not analyze data from two smaller gaps of 100 and 640
base pairs (bp) respectively due to an inability to align reads to
sequence gaps in the reference genome (0.3% of total
sequence). These regions were subsequently sequenced with
traditional Sanger technology, and analysis did not reveal any
additional polymorphic sites. Except for these gaps, the
coverage generated by Illumina sequencing was high at all
positions, including those with high GC content, with a
minimum depth of 25X at a few positions. All sequences within
the MCOA interval were mined for SNPs, structural changes,
and insertions and deletions (indels).
Polymorphism evaluation
In total we identified 609 SNPs, of which 23 were localized
within conserved elements according to the 29 mammal
dataset [26]. All ten re-sequenced horses were homozygous for
the same allele at 60 of these SNPs, with the opposite allele
only present within the reference genome. For indels we used
quite a low quality filter even though this would give an
increased number of false positives. Using this threshold we
detected 129 possible indels. We manually inspected the reads
of all indels positioned in conserved elements according to 29
mammal conservation scores and could confirm that eight out
of 27 appeared real. We did not identify any structural
rearrangements, large duplications or deletions.
Association study
At either end of the sequenced IBD region there was a
cluster of SNPs that could be used to clearly narrow the MCOA
haplotype. Taken together, these excluded 14.4 kb, leaving a
193.3 kb IBD-region. At the 5’ end, the two Rocky Mountain
Horses carried a different haplotype compared to the Icelandic
and American Miniature Horses, while at the 3’ end, the Cyst-
phenotype horse did not carry the MCOA associated
haplotype.
In order to minimise the number of candidate mutations,
optimum controls had been selected from a larger cohort of
genotyped horses presented in an earlier study [14]. The
criterion for inclusion as a control in the current study
demanded a careful ocular examination and a haplotype similar
to the disease haplotype. After we excluded all SNPs and
indels that did not exactly match the correct inheritance
patterns of the syndrome i.e horses with the MCOA-phenotype
homozygous for one allele, Cyst-phenotype horse
heterozygous and unaffected horses homozygous for the
opposite allele, only two SNPs remained (Table 2). Both of
these are positioned within the PMEL gene and have
previously been associated with the Silver coat color [12,13].
One of these, g.73666064A>T is located in intron 9 and not
within a conserved element. The hypothesis of a potential gain
of function caused through the generation of a transcription
factor motif was tested, however we could not find any
supporting evidence that a known mammalian transcription
factor binding site was created as a result of the SNP. The
second SNP, g.73665304C>T, is positioned 760 bp
downstream of the intronic SNP. This variant is not only
conserved, but is also coding, positioned in the last exon of
PMEL, exon 11. It introduces an amino acid change from an
arginine to a cysteine (Arg625Cys) in the second position of the
cytoplasmic region.
In an effort to exclude the intronic SNP as causative we
genotyped it in a random set of 936 horses. Of these, all Silver
horses (n= 24) and some chestnut horses (n= 4) were
heterozygous or homozygous for the T allele. Subsequent
genotyping of the coding SNP revealed that they were either
Table 1. Summary of data generated by Illumina sequencing for the MCOA syndrome identity-by-decent (IBD) region
(ECA6: 73640494-73848154).
ID Phenotype Breed Total yield(Giga bases) Mapped reads (%)* Mapped reads to IBD-region (%) Average coverage IBD- region (X)
Horse 1 MCOA American Miniature 2.4 95.4 93.1 10901.8
Horse 2 MCOA Icelandic Horse 2.8 94.8 91.1 12624.0
Horse 3 MCOA Icelandic Horse 2.8 97.8 96.0 13385.2
Horse 4 MCOA Rocky Mountain Horse 3.0 96.6 94.5 13522.2
Horse 5 MCOA Rocky Mountain Horse 2.4 94.6 92.4 11187.2
Horse 6 Cyst American Miniature 2.8 94.1 90.7 12615.1
Horse 7 Unaffected American Miniature 2.6 97.0 95.1 11493.6
Horse 8 Unaffected American Miniature 2.4 94.9 92.4 11104.2
Horse 9 Unaffected Rocky Mountain Horse 2.4 92.4 90.8 10489.8
Horse 10 Unaffected Rocky Mountain Horse 12.4 97.9 96.5 57357.6
*. Against the whole genome
doi: 10.1371/journal.pone.0075639.t001
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heterozygous or homozygous for the T allele in the coding SNP
i.e. the alleles were in complete LD. None of the other 908
horses carried the T allele at the intronic SNP, demonstrating
that this variant may be unique to the Silver haplotype.
Discussion
This study establishes that PMEL is causative for MCOA
syndrome. We were able to systematically exclude all other
candidate genes from a previously identified 208 kb IBD-region
using the results of deep sequencing, and in doing so clearly
demonstrate the usefulness of this method for finding causative
mutations, especially for monogenic disorders where there is a
simple relationship between genotype and phenotype. A
common outcome of many deep-sequencing projects is the
large number of potential candidate mutations identified. In this
study, we also show the benefits of well-selected controls. We
genotyped control individuals for markers within and flanking
each side of the established IBD-region and used this
information to identify those that harboured either the ancestral
haplotype or that were very close to the disease haplotype for
sequencing. By doing so, we dramatically reduced the number
of candidate mutations that required validation in additional
animals. Further, by using long-range PCRs to build our
libraries we were able to cover sequence that may have been
missed with other technologies, such as genome gaps and
long repeats, which are excluded during sequence capture.
More than 90% of our reads mapped to the expected genetic
interval with some loss likely due to poor alignment of repetitive
sequences in the region.
The previously characterized MCOA syndrome region was
208 kb and contained 15 genes, of which several were
potentially important for eye development. In this study we
manage to exclude all polymorphic sites, barring two SNPs in
PMEL, and propose that the causative mutation is a missense
mutation in exon 11 which leads to an arginine to a cysteine
(Arg625Cys) change in the second codon of the cytoplasmic
region. PMEL is a pigment cell-specific integral membrane
protein found in the melanosomes of cells synthesizing
primarily the black and brown pigment, eumelanin [27,28].
Subsequent to cleavage, PMEL forms amyloid fibrillar sheets
on which melanin is deposited [29]. These sheets form the
structural foundation of eumelanosomes and define the
organelles maturation stages [30]. The exact function of the
fibrillar sheets is not completely understood but they are
suggested to have a role in the processing of melanin
intermediates, facilitating their polymerization, intracellular or
Table 2. Identified polymorphic sites which fitted the
expected inheritance pattern and so qualified as candidate
mutations for MCOA syndrome.
Position
Reference
allele
Mutant
allele ConservedCoding
Predicted
consequence
chr6:73666064 A T no no none
chr6:73665304 C T yes yes Arg625Cys
doi: 10.1371/journal.pone.0075639.t002
intercellular transfer and/or detoxification [24,28,31]. The first
cleavage that PMEL is subjected to breaks the protein into Mα
and Mβ fragments. Paradoxically, the Mα fragment forms the
actual fibrils important to melanin deposition while the horse
missense mutation is within Mβ.
Fortunately, the molecular effects of the two dominant PMEL
mutations, Silver in horse and Dominant white in chickens,
have recently been studied in detail [24]. This has been
accomplished by introducing mutations analogous to these in
the context of human PMEL and subsequently evaluating
protein function relative to the wild-type form. The horse
mutation is positioned very close to the transmembrane domain
(TMD) and whereas the wild-type TMD is not able to
oligomerize, the mutant form gains this function and can readily
self oligomerize. The horse mutation replaces the middle of
three consecutive arginines with a cysteine. This new
oligomerization ability of the TMD was therefore suggested to
be a consequence of decreased electrostatic repulsion
between the adjacent basic RRR motifs via the removal of a
positive charge [24]. When examining the full-length PMEL, the
TMD mutation did not alter protein trafficking or its ability to be
processed into amyloidogenic Mα fragments. However, at the
end of the cleavage process when a yet unidentified protease
cleaves Mβ, there is a small difference in mutant versus wild-
type PMEL processing. In wild-type PMEL, Mβ is digested into
two different c-terminal fragments (CTF). In contrast, the
mutant protein is predominantly digested into just one form,
and this seems to be more stable. The consequence of this
second finding remains to be evaluated, but may be less
drastic than the gain of self oligomerization properties of the
TMD [24].
Upon maturation of profibrils into elongated fibrillar sheets,
human PMEL containing the analogous horse mutation shows
marked differences to the wild-type. In mouse melanocyte cell
lines expressing the latter, most stage III and IV melanosomes
were densely pigmented. In cells expressing the mutant form,
there was less space between the fibrils and the sheets
appeared abnormally tightly packed. Exactly how the new TMD
oligorization properties affects fibrillar sheet formation remains
to be elucidated. Importantly though, and probably because of
this arrangement, the organelles seemed to lack pigmentation.
This finding suggests that either the fibrils were no longer
capable of binding to melanins or melanin production was
somehow inhibited. EM analysis revealed that cells expressing
mutant PMEL were hypopigmented, harbored fewer pigmented
melanosomes and were enriched in early stage melanosomes
[24].
These data clearly demonstrate a significant functional
consequence of the missense mutation and provide convincing
evidence that the coding PMEL mutation is causative for both
MCOA syndrome and the Silver phenotype in horses. The
obvious further question involves how alterations in the
properties of pigmented cells change the whole structure of the
eye to a pathologic form. It is not yet known why PMEL
mutations give ocular anomalies in some species such as dog,
horse and zebrafish, but not in chicken, cow and mouse. This
is an interesting topic for further research. Because the
Mutant PMEL Causes MCOA Syndrome
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relatively mild phenotype in the null mice, all other known
PMEL mutations are suggested to be dominant negatives [23].
The silver mutation in mice consists of a single nucleotide
insertion that leads to a premature stop codon and a truncated
protein, which is missing the last 25 C-terminal amino acids
[16,32]. The mutation causes a dilution of eumelanin, which
results in the premature graying of the hair due to the loss of
follicular melanocytes [33]. In frame insertion/deletions in
chicken PMEL are associated with the Dominant white, Dun
and Smoky coat colors [17]. Dominant white chickens are
completely white and have a nine base pair in frame insertion
within the PMEL TMD. These chickens do not present with any
ocular anomalies but the homozygotes appeared less
pigmented in the outer layers of the choroid than their wild-type
counterparts, while the pigment of the retina pigmented
epithelium seemed to be unaltered [25]. Interestingly, a second
mutation found in a flock of Dominant white chicken, causing
the Smokey phenotype, dampens or prevents the accumulation
of the pathogenic PMEL isoforms [24]. This mutation behaves
like PMEL knockouts and has a much milder phenotype, again
suggesting that it is better to have no PMEL at all than the TMD
mutant forms. In cattle, dilution of coat color pigment is
associated with a missense mutation as well as a three
nucleotide, in frame deletion, both residing in the signal peptide
of PMEL [15,34]. . The zebrafish mutant, fading vision, exhibits
both defects in vision and hypopigmentation and has a point
mutation in PMEL, which leads to a truncated protein [18]. The
merle patterning of the domestic dog is characterized by
patches of diluted pigment and is presumed to be caused by a
retrotransposon insertion into intron 10 of PMEL [19]. Some
homozygous merle dogs suffer from both auditory and
ophthalmologic abnormalities, defects that are similar to those
of the human auditory-pigmentation disorder, Waardenburg
syndrome [20]. No mutations in human PMEL associated with
pigmentation variation have yet been described, but they are
likely to exist.
The link between coat color and eye development is not
novel and several other known or suggested mutations for coat
color have pleiotropic effects, as reviewed in Bellone [35]. In
horses these include vision abnormalities (Congenital
stationary night blindness in leopard spotted horses), deafness
(frame overo patterning and sometimes splashed white
patterning), defects in the nervous system (Lethal white foal
syndrome in frame overo horses and Lavender foal syndrome)
as well as in melanomas (in grey horses) [35,36]. The
identification of the MCOA mutation is important not only for
resolving the controversial function of PMEL, but it also has
practical implications for horse breeders. Molecular testing of
the Silver mutation can inform breeding decisions, which is
especially meaningful for chestnut or related colors where it is
impossible to know if individuals carry the mutation by coat
phenotyping alone. Our advice to breeders is to avoid breeding
Silver horses to each other. This will essentially eliminate the
risk of breeding foals affected by the MCOA phenotype.
Conclusion
The missense mutation g.73665304C>T in the cytoplasmic
region of PMEL causes both MCOA syndrome and the Silver
coat color. This conclusion is based on the fact that deep
sequencing and subsequent analysis eliminated all other
possible candidate genes from the IBD-region, and that
functional data presented by others showed that the missense
mutation causes PMEL function alterations and subsequent
changed melanocyte structure.
Materials and Methods
The study was approved by the Ethics Committee for Animal
Experiments in Uppsala, Sweden as well as by the Institutional
Animal Care and Use Committee at Michigan State University.
Horses
Five horses with the MCOA phenotype (2 Icelandic Horses, 2
Rocky Mountain Horses and 1 American Miniature Horse), one
horse with the Cyst phenotype (American Miniature Horse) and
four unaffected controls (2 Rocky Mountain Horses and 2
American Miniature Horses) were selected for massively
parallel Illumina sequencing. The horses were previously
genotyped using a combination of SNP and microsatellite
markers, both within and around the MCOA genetic interval, as
part of another study [14]. A comparison between the MCOA
haplotype and the haplotypes of each unaffected horse as well
as for the horse with the Cyst phenotype is found in Table S1.
The anterior and posterior segments of the eyes had also
previously been examined by slit-lamp biomicroscopy and
indirect ophthalmoscopy before and after induction of mydriasis
with tropicamide eye drops [1,3]. The set of 941 random horses
included in this study comprised American Miniature Horses
(n= 8), Arabian Horses (n=19), Ardennes (n= 21), Cold
Blooded Trotters (n= 213), Dole Horses (n= 16), French
Trotters (n= 56) Gotland Ponies (n= 29), Icelandic Horses (n=
185), Kentucky Mountain Horses (n= 23), North Swedish Draft
Horses (n= 38), Rocky Mountain Horses (n= 17), Shetland
Ponies (n= 30), Standardbreds (n= 174), Swedish Warmbloods
(n= 70) and Thoroughbreds (n= 37).
PCR Amplification
Primer3plus [37] was used to design primers for a previously
identified Identity-by-decent MCOA interval (EquCab2, Chr6:
73640494-73848154). The 208 kb region was amplified using
40 primer pairs (Table S2). Touch down PCR reactions
(68°C-55°C, lowering -0.5°C/cycle) were carried in a total
volume of 25 µl; 80 ng genomic DNA, 0.5 units KOD Hot Start
DNA Polymerase (Novagen), 1.5 mM MgSO4, 1X KOD buffer,
0.20 mM dNTP, 5.0 µl Betain (Sigma B-0300), 0.28 mM
forward primer, 0.28 mM reverse primer. Products were gel
purified using Qiaquick Gel Extraction kit (QIAGEN) and
amplicons from each horse were subsequently pooled.
Library Preparation and Sequencing
Sequencing libraries were prepared from 1.5 µg of DNA
according to the TruSeq DNA sample preparation guide
Mutant PMEL Causes MCOA Syndrome
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#15005180 revA using reagents from the TruSeq DNA sample
prep kit set A and set B v1 (Illumina). Briefly, DNA was
fragmented using the Covaris S2 system (Covaris), overhangs
were end-repaired followed by purification using AMPure XP
beads (Beckman Coulter). An A-base was added to the blunt
ends of the DNA fragments and adapters and indextags for
sequencing ligated, followed by purification using AMPure XP
beads. The DNA fragments and the library was size selected
on a 2% agarose gel and the fraction containing a 500bp
fraction containing the adapter ligated fragments was excised
from the gel, purified using a QIAGEN gel extraction column
(Qiagen) and amplified for 10 cycles of PCR, followed by
purification using AMPure XP beads (Beckman Coulter). The
quality of the libraries was evaluated using the Agilent
Technologies 2100 Bioanalyzer and a DNA 1000-kit. The
adapter-ligated fragments were quantified by qPCR using the
Library quantification kit for Illumina (KAPA Biosystems) on a
StepOnePlus instrument (Applied Biosystems/Life
technologies) prior to 16 pM of the pooled libraries being
subjected to cluster generation on the cBot instrument (Illumina
Inc.) using TruSeq PE cluster generation kit v3. Paired-end
sequencing was performed for 100 cycles in one lane using a
HiSeq2000 instrument (Illumina Inc) and TruSeq SBS
chemistry v3, according to the manufacturer’s protocols. Base
calling was done on the instrument by RTA 1.12.4 and the
resulting. bcl files were converted to Illumina qseq format with
tools provided by OLB-1.9.0 (Illumina Inc.). To separate
samples and PhiX control DNA sequenced in the same lane as
the sample libraries, the qseq-files were demultiplexed,
allowing for one mismatch. Both demultiplexing and mapping
were done with CASAVA 1.7.0 (Illumina Inc.). Additional
statistics on sequence quality were compiled from the base call
files with an in-house script. Sequencing was performed by the
SNP&SEQ Technology Platform in Uppsala, Sweden
(www.sequencing.se).
Data analysis
Standard methods for sequencing read alignments and
variant detection were used. The Burrows-Wheeler Alignment
tool (BWA) [38] was used for alignment to the horse genome
(equCab2) [39]. Samtools software package [40] was used to
analyse the aligned data. Data was first aligned, then
converted to bam format, and subsequently sorted and
indexed. We used BedTools [41] to calculate the depth and
breadth of coverage for our selected target region with the
coverageBed command. The mpileup command in Samtools
[40] was used for SNP and indel calling (http://
samtools.sourceforge.net/mpileup.shtml). The Buf command
was used to keep the read depth. The Samtools program
bcftools was used for SNP and indel calling and for output in
the vcf format. Only qualities above 20 were included for further
analyses based on a PHRED scale. Additional filtering with
Varfilter was applied with minimum and maximum depth set at
50 vs. 100,000 to adjust for twice the average coverage. Indel
calling generated some false positives (including real ones)
that where analysed manually in Integrative Genomics Viewer
(IGV, www.broadinstitute.org/software/igv/home) before
exclusion. We also used Samtools pileup to extract the
coverage for each single base for use in relative coverage
calculations.
Further analyses of the data were performed with Seqscoring
(http://www.seqscoring.org/) [42]. Detected SNPs and indels in
vcf format were first scored by conservation across species.
Constraint elements from 29 eutherian mammals [26] were
used for comparison and scoring. The results from all samples
were then merged into one file and displayed in the UCSC
browser (http://genome.ucsc.edu/) to allow for comparison and
interpretation in the case control association study. Finally, we
performed a relative coverage assessment to identify larger
insertions, copy number variations or deletions that differed
between cases and controls. Samtools pileup files were used
as input and output files were displayed in the UCSC browser
(http://genome.ucsc.edu/) for interpretation.
Evaluation of candidate mutations
Transcription factor binding site analysis was performed
using CONSITE (http://asp.ii.uib.no:8090/cgi-bin/CONSITE/
consite) [43]. The genotypes of the two PMEL mutations from
the set of random horse breeds was assessed through Custom
TaqMan SNP Genotyping assays (Carlsbad, USA). Primer and
probe designs were obtained from ABI webpage (https://
www5.appliedbiosystems.com/tools/cadt/). The following
sequences were used to genotype the exon 11 SNP; forward
primer: 5’-TCCATTGCTTACCAGTTTCCTTCTT-3’, reverse
primer: 5’-GAGAGCTGAGCCCTGCTT-3’, reporter 1: 5’-
CATAAGTCTGCGCCTGAT-3’, reporter 2: 5’-
CATAAGTCTGCACCTGAT-3’. The following sequences was
used to genotype the intronic SNP; forward primer: 5’-
GCACAGCTTCAGTCAGTGTCT-3’, reverse primer: 5’-
GGTAGGTACTTGGACAAGATCTAGGA-3’, reporter 1: 5’-
CTGCCAGATAGCCTCT-3’, reporter 2: 5’-
TGCCAGAAAGCCTCT-3’. The ABI PRISM 7900 HT sequence
detection system for 384-well format was used for the analysis
according to manufacturers’ instructions.
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